GSK’s Nucala Phase III trial shows promise in treating chronic lung disease
September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical.
Drugs
Health
Pharma
Health
Medical
Pharma
Harvard’s ChatGPT-like AI model can predict tumours, detect cancer
Harvard Medical School scientists have designed an artificial intelligence model similar to ChatGPT that detects cancer or predicts a tumour’s genetic profile.
Drugs
Health
Medical
SDG targets in danger as paychecks shrink globally, ILO says
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030.
Drugs
Health
Pharma
First batch of Bavarian Nordic’s mpox vaccines in Congo by Sept. 5
The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in.
Drugs
Health
Pharma
Aid workers begin second round of polio vaccinations in Gaza, a 3rd on way
A second phase of the polio vaccination will start today in war-raved Gaza after 187,000 children under the age of 10 got oral.
Drugs
Health
Pharma
Abbott starts trial on deep brain stimulation for depressive disorder
Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a.
Drugs
Health
Pharma
Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.
Drugs
Health
Pharma
Cholera killed 4,000 people last year, current global risk of disease ‘high’
Cholera cases rose 13% and deaths by 71% in 2023 compared to a year earlier as a shortage of oral vaccines continues and.
Drugs
Health
Pharma
WHO issues first-ever guidelines on manufacture of antibiotics
The World Health Organization has come out with its first-ever guidelines for the manufacturing of antibiotics in a bid to stop environmental emissions and.
Drugs
Health
Pharma
EC approves Merck’s bladder cancer combination therapy in adults
Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in.